Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 591-600 of 2651

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Study to Improve health-related quality of life (HRQOL) in Black Prostate Cancer Patients (CaPQoL) through Whole Person Survivorship Care

    Jacksonville, FL

  2. Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

    Rochester, MN

  3. A Phase 2/3 Study of Andecaliximab in Participants with Fibrodysplasia Ossificans Progressiva (FOP) in Two Parts with an Open-Label Extension (OLE) (ANDECAL)

    Rochester, MN

  4. A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, or 7+3 in Patients With AML

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Study to Evaluate Combination Therapy to Treat Newly-diagnosed Diffuse Anaplastic Wilms Tumors and Relapsed Favorable Histology Wilms Tumors A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

    Rochester, MN

  6. CAST-AI: Cystectomy after systemic therapy with ADC and Immunotherapy

    Rochester, MN

  7. SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer Surgery

    Rochester, MN

  8. Effect of training the breathing muscles on the ability to exercise in people with non-cystic fibrosis bronchiectasis

    Jacksonville, FL

  9. T2 Lens Study

    Rochester, MN

  10. Evaluate REC-4881 in Patients With FAP (TUPELO)

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer